Helps in tissue formation
Here is how tirzepatide stacks up against the alternatives, with specific attention to male outcomes
DAMP signaling networks: from receptors to diverse pathophysiological functions
Weight loss injections approved by the FDA for chronic weight management include glucagon-like peptide-1 (GLP-1) receptor agonists such as semaglutide (Wegovy) and the dual glucose-dependent insulinotropic polypeptide (GIP)/GLP-1 receptor agonist tirzepatide (Zepbound)
Our previous work concluded that this was a consequence of glucagon deficiency rather than improved insulin sensitivity or secretion, as determined by a hyperinsulinaemiceuglycaemic clamp and an IVGTT [9]
Liu B, Xu M, Wang J, Wang Z, Zhao L (2021b) Ecological risk assessment and heavy metal contamination in the surface sediments of Haizhou Bay, China